OncoHost to Present New Research on Early Detection of Immunotherapy Resistance Using Plasma Proteomics at ISLB 2026

The Quick Take
New data demonstrates the potential of longitudinal plasma proteomics to detect disease progression ahead of radiologic assessment and predict overall survival in advanced NSCLC BINYAMINA, Israel and CARY, N.C., Nov. 5, 2026 /PRNewswire/ -- OncoHost, a technology company transforming...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Reap, Meitu's EveLab Insight, and Pivota Sign MOU to Explore Bringing Agentic Beauty Shopping to Life
The collaboration would connect personalized consumer experiences and the checkout experience with Reap's agentic payments solution HONG KONG, Nov. 5, 2026…
Business
Rheinmetall shares slump 16% after second 2026 outlook cut in Q3 results
Business
UBS downgrades PagSeguro stock rating on rate concerns
Business
